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SH3 and W domains are involved in a variety of 
intracellular signaling pathways. Recent work has shed 
light on the mechanism whereby these signaling 
modules recognize prolines in polyproline ligands, 
which has implications in the design of ligands 
selectively targeting these interactions. 
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Signal transduction refers to the transmission of extracellu- 
lar information, in a coordinated, spatially defined manner, 
to intracellular targets. Information transfer occurs primar- 
ily through changes in molecular interactions or covalent 
modification of proteins, peptides, lipids and other small 
molecules [l]. These lead to a variety of events including 
all,osteric modulation of enzyme activity, formation of mul- 
timolecular assemblies or changes in intracellular localiza- 
tion. The result is often a net increase in the local 
concentration of primed molecules capable of further 
propagating the signal to additional downstream effecters. 
The majority of molecular interactions in signaling path- 
ways are governed by a small set of conserved, noncatalytic 
protein domains. These modules, which include SHZ, 
SH3, WW, PDZ, PTB and EH domains, each recognize a 
specific peptide motif in their targets (for recent reviews 
sece [2,3]). The binding domains are arrayed in signaling 
pr’oteins in a combinatorial fashion, along with various cat- 
alytic domains, enabling individual molecules to integrate 
information from multiple sources. Such integration gives 
rise to the highly interconnected nature of signaling net- 
works in the cell. The molecular mechanisms of target 
recognition by the modular binding domains have been 
the focus of extensive studies and have been reviewed in 
detail elsewhere. Here we focus on the recent work by 
Nguyen et al. [4] on ligand recognition by SH3 and WW 
domains. The unexpected mode whereby these domains 
bind peptides has implications for the design of high-affin- 
ity and highly specific molecules targeting individual path- 
w:ays. As a point of comparison, we begin by briefly 
reviewing ligand recognition by SHZ domains. 
Among the most extensively studied signaling modules are 
the Src homology II (SHZ) domains, commonly found in 
tyrosine kinase signaling pathways. These domains bind 
phosphotyrosine (pTyr or pY) in specific sequence con- 
texts, thereby acting as sensors of tyrosine kinase activity. 
SHZ domains are compact structures of approximately 100 
amino acids formed by a central B sheet inserted between 
two a helices (Figure la). Peptides are bound in an 
extended conformation perpendicular to the plane of the 
sheet at one edge, with the pTyr residue inserting into a 
cleft bordered by the sheet and the amino-terminal helix. 
Residues of the ligand carboxy-terminal to the pTyr are 
recognized by regions of the SHZ domain bordered by the 
B sheet and the carboxy-terminal helix. The affinity of 
physiological ligands is typically in the range 0.1-l PM [S]. 
Binding of a specific peptide involves two levels of recogni- 
tion. First, phosphotyrosine must be recognized relative to 
tyrosine. This has been achieved through the construction 
of the pTyr binding pocket (Figure la). The most con- 
served feature of this cleft is a buried arginine sidechain 
(Arg BBS), whose guanidinium amino groups form biden- 
tate hydrogen bonds to the phosphate moiety on pTyr [6]. 
Additional electrostatic and hydrophobic contacts with the 
pTyr sidechain vary among different SHZ domains. In all 
cases, however, the pTyr sidechain is nearly completely 
buried in the complex, virtually exhausting the binding 
potential of this residue. The complementary geometries 
and precise positioning of the SHZ BBS arginine and ligand 
pTyr sidechains are key in the interaction (Figure la), ren- 
dering SH2 Arg(BBS)+Lys mutants or ligands containing 
nonaromatic phosphoserine and phosphothreonine residues 
ineffective binders to the wild-type partner [7]. Similarly, 
the burial of an unsatisfied charge on Arg(BB5) by nonphos- 
phorylated ligands substantially decreases their affinities 
for the domain. The second level of specificity involves the 
ability of different SH2 domains to discriminate between 
different pTyr peptides. This specificity is conferred by 
three to five amino acids carboxy-terminal to the pTyr 
residue. A given SH2 domain will show preference for dif- 
ferent amino acid types at the individual positions. These, 
preferences are not strict, however, and are based on the 
character of the interaction (charged or hydrophobic) rather 
than the specific stereochemical properties of the side- 
chains. Many SH2 domains contain a shallow hydrophobic 
pocket that recognizes a hydrophobic sidechain of the 
ligand three residues carboxy-terminal to the pTyr (the +3 
position, Figure 2a). Alternatively, a second smaller class of 
SH2 domains contain a more extended hydrophobic groove 
that recognizes aliphatic residues at the +l, +3 and +5 posi- 
tions of the ligand (Figure 2a). As an example of the first 
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Figure 1 
Ligand recognition by SH2 and SH3 domains. 
(a) Ribbon [33] diagram of Src SH2 (blue) 
complexed with a phosphotyrosine ligand, 
pYEEl (yellow backbone with red sidechains) 
[6]. Sidechains of residues in the 
phosphotyrosine binding pocket are shown in 
green. (b) Ribbon [33] diagram of Crk-SH3 
(blue) in complex with a designed high-affinity 
ligand containing a N-(S)-phenylethyl group 
141. SH3 sidechains contacting the proline 
core of PPII ligands are shown in green, the 
ligand is shown in yellow with red sidechains. 
Residue numbering is according to 141, using 
single-letter amino acid code. 
mode, the SH2 domains of Src and Lck bind peptides 
containing a pYEE1 motif (where E is glutamate and I is 
isoleucine) [6,8]. The glutamic acid residues make loose 
contacts with positively charged solvent-exposed residues, 
whereas the isoleucine residue is bound in a well-defined 
cavity formed by two loops bordering the carboxy-termi- 
nal helix (Figure la). Variations in the amino acid 
sequence within these loops is thought to be at least in 
part responsible for determining specificity toward 
ligands. Evidence for this was provided by Marengere 
et al. [9] who show that a mutation of a threonine in Src- 
SH2 EF loop to a tryptophan residue (found at this posi- 
tion in Grb2 SHZ) changed ligand specificity to resemble 
that of Grb2 SHZ. Thus SH2 domains bind ligands 
through the conserved recognition of a pTyr followed by 
several carboxy-terminal residues, which impart speci- 
ficity through less well-conserved interactions. 
Figure 2 
The structurally unrelated SH3 and WW domains bind 
polyproline motifs [l,lO], which are functionally analogous 
to pTyr in SH2 recognition. Proline residues within these 
motifs make key contacts with conserved elements of the 
protein surfaces, while surrounding residues serve to 
confer specificity through interactions with more variable 
regions. WW domains are small (< 40 residues) protein 
modules consisting of a slightly twisted three-stranded 
antiparallel p sheet [l 11. A hydrophobic patch, created by 
aromatic and methyl-containing residues on one face of 
the sheet, forms the ligand binding surface [ll]. SH3 
domains are comprised of roughly 60 residues, forming two 
three-stranded antiparallel a sheets packed at approxi- 
mately right angles with respect to one other (Figure 1 b) 
[12]. A cluster of aromatic residues from three strands form 
a curved surface on one edge of the molecule, which, along 
with two adjacent loops, create the ligand-binding site 
Grasp [34] surface representation of SH2 
and SH3 domains complexed with ligands 
(stick models). (a) Src-SHP domain bound to 
pTyr peptide [6]. (b) Crk-SH3 domain bound 
to a high-affinity ligand designed by Nguyen 
et al. [4]. The P, site contains an 
N-(S)-phenylethyl group instead of a 
proline sidechain in the wild-type peptide. 
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(Figures lb,Zb) [13,14]. X-ray and nuclear magnetic reso- 
nance (NMR) studies indicate that both SH3 and WW 
do:mains interact with proline-containing ligands in a left- 
handed type II helix (PPII helix) conformation [14,15]. 
The consensus binding sequences for these modules are 
xPxxP (SH3) and PPxY or PPLP (WW) (where P is 
proline, x any nonproline amino acid and L is leucine) 
[16,17], and binding is abolished in mutants where pro- 
lines are replaced by other amino acids [4,14,16]. The SH3 
binding site is composed of three pockets, two of which 
bind XP elements in the recognition motif. Remarkably, 
ligands are capable of binding in either of two orientations 
having opposite directionality of the backbone [15,18]. 
Interactions of residues flanking the proline motif with the 
third pocket control orientation, and SH3 residues in the 
n-!jrc- and RT-loops (B3-p4 and Bl-B2, respectively) 
lining this pocket are the primary determinants of ligand 
specificity (Figure 2b) [19,20]. Specificity of WW domains 
is conferred by contacts to the final residue in the consen- 
sus sequence of the ligands [ 111. For both SH3 and WW 
domains, affinity for polyproline ligands is low, typically in 
the micromolar range [14,18]. Furthermore, despite the 
specificity constraints, individual SH3 domains are capable 
of binding, with varying degrees of promiscuity, a series of 
SH3 ligands [17,21], and the same ligand has been shown 
to bind both WW and SH3 domains in vitro [ 171. 
To date, most studies of SH3-ligand specificity have 
focused on the nonproline residues in the PPII helices, as 
well as residues outside of these regions. Results from 
biased combinatorial peptide libraries of the form xxxPPx- 
Pxx as well as phage display libraries have been particu- 
larly informative in this regard [14,22,23]. Using the 
former, Chen eta/. [Z] first identified two classes of SH3 
ligands, characterized by an arginine residue either three 
residues amino-terminal (class I) or two residues carboxy- 
terminal (class II) to the PxxP core. Subsequent structural 
and biochemical analyses established that this arginine 
residue forms energetically favorable contacts with an 
aspartic acid in the SH3 domain RT loop in both ligand 
classes, dictating opposite orientation of the backbone in 
thse two cases [15,18]. Analogous data on the Abl SH3 
domain have similarly established that residues amino-ter- 
m:inal to the PxxP core of a ligand derived from its partner, 
3ELP1, make energetically important contacts to the 
RT loop. Interactions with the specificity pocket has also 
be:en exploited in the design of nonpeptide libraries 
attached amino-terminally to a common LPPLP core 
[24,2.5]. These libraries led to identification of high-affinity 
small molecule-peptide hybrids that, based on structure 
de:termination of their complexes with an SH3 domain, 
re,cognize the specificity pocket in a manner distinct from 
natural ligands. Comparison of library-derived class I 
ligands for Src-, PI3K- and Abl-SH3 domains has also 
revealed different preferences for nonproline residues in 
individual XP elements in the core binding region. 
Although Src and PI3K prefer LP in the amino-terminal 
element, Abl prefers PP; in the carboxy-terminal element, 
Src prefers LP whereas PI3K selects for RP [23]. In both 
cases, these differences have been attributed to variations 
in the n-Src loop of the SH3 domains, which contacts the 
first residue in XP elements of class I ligands. The culmina- 
tion of these findings were reported by Pisabarro et al. [26] 
who have recently shown how an increase in affinity and 
specificity can be achieved by rationally optimizing the 
interactions of a ligand with both the specificity and 
proline binding pockets. On the basis of the crystal struc- 
ture of the Abl-SH3 domain in complex with a native 
3BPl peptide, they designed a ligand that had a 30-fold 
higher affinity for AM-SH3, and 150-fold greater selectivity 
toward the Fyn SH3 domain [26]. This was accomplished 
by replacing methionine and proline residues adjacent to 
the PPII helix by tyrosine and serine, respectively, as well 
as a leucine within the polyproline region by proline [26]. 
The crystal structure of the optimized ligand bound to the 
Abl-SH3 domain reveals that the hydroxyl group of the 
tyrosine aromatic ring forms favorable hydrogen bonds 
with serine and aspartate residues on the protein. In Fyn- 
SH3, the serine and aspartate residues correspond to an 
arginine and a glutamine residue, respectively. Together 
with replacement of a glycine (AM-SH3) located in the 
RT loop by a threonine (Fyn-SH3), these larger amino 
acids would probably prohibit the binding of the tyrosine 
because of steric clashes, explaining the lower affinity 
observed for Fyn. The mutation to a serine enables the for- 
mation of an intraligand hydrogen bond between this 
residue and an adjacent proline. As a result, the two halves 
of the ligand are displaced with respect to each other, cre- 
ating a more favorable positioning of the two regions for 
SH3 binding. Circular dichroism data indicate that the 
mutation of a solvent-exposed leucine residue to a proline 
at the pl position (Figure 2b) stabilizes the PPII helix, 
resulting in entropic benefits for complex formation [26]. 
The importance of proline in SH3 and WW recognition 
has been attributed, in part, to the ability of this residue to 
induce PPII helices, providing optimal spacing of residues 
recognized by the binding surface of the domains. There 
is also evidence for a direct role in mediating unique con- 
tacts within the SH3 and WW domain binding sites. 
Lim et a/. [15] have demonstrated by molecular modeling 
that, depending on the relative orientation of the ligand, 
residues in PPII helices pack with their Cp atom directed 
either toward (internal packing) or away (external packing) 
from the protein surface (Figure 3). Correspondingly, the 
group bonded to the amide nitrogen, H or CH,, is directed 
either away (internal packing) or toward (external packing) 
the interface. In the latter case, the hydrophobic pockets 
of the SH3 and WW domains would strongly disfavor 
interactions with nonproline residues, whose backbone 
amide protons would be targeted into the binding site. 
N-alkyl substitution of prolines, however, enables their 
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‘\ A’ \ 
d,-N 
/ 
Chemistry & Biology 
Schematic depiction of external versus internal binding modes of 
proline residues in PPII helices (see text). Adapted from [4]. 
sidechains to turn inward and make appropriate hydropho- 
bic contacts with the domain surface (Figure 3). 
In their recent publication, Nguyen et a/. [4] further 
refined the role of proline in these interactions through 
elegant studies of synthetic SH3/WW ligands containing 
noncyclic N-alkylated amino acids. They designed a series 
of peptides in which residues in the proline-rich core of 
several natural SH3/WW ligands were individually 
replaced by either aianine or sarcosine (N-methyl glycine; 
Figure 4). Alanine mutants of conserved prolines show 
reduced affinity, whereas ligands containing sarcosine at 
these sites bind their target domains with affinities com- 
parable to that of wild-type peptides, showing that the 
rigidity and shape of the proline ring are dispensable in 
the interaction [4]. They argued, therefore, that it is 
largely N-substitution at key positions in the ligand that is 
recognized by SH3 and WW domains rather than the par- 
ticular geometric properties of the proline residue. 
In contrast to earlier focus by others on the regions outside 
of polyproline motifs, Nguyen et al. [4] demonstrated how 
optimizing the contacts to the proline-binding regions of 
SH3 domains can be exploited as an alternative approach 
in the design of high affinity ligands. Having established 
the importance of N-substitution in PPII recognition, they 
synthesized a series of 12mer SH3 ligand mutants in 
which either of the two conserved prolines in the XPXXP 
motif was replaced by a non-natural N-substituted amino 
acid. In fluorescence binding assays they found the affin- 
ity of most of these ligands for the carboxy-terminal SH3 
Proline 
Alanine Sarcosine 
Me MB 
HN 
/ 
CO 
N-(S)-phenylethylglycine 
co 
co Chemdy 8 Biology 
Chemical structures of proline, alanine, sarcosine and 
N-(S)-phenylethylglycine. 
domain of Sem5, the amino-terminal SH3 domains of 
Grb2 and Crk, and the SH3 domain of Src [4] to be com- 
parable to wild type. Unfavorable binding was observed 
for N-alkyl residues with charged groups. This is consis- 
tent with the predicted binding mode in which externally 
packing residues orient their N-alkyl moieties toward the 
binding surface, which for SH3 and WW domains is 
hydrophobic. Conversely, several ligands bound the SH3 
domains with higher affinities than the proline-containing 
analogs. The tightest binding ligand contained an N-(S)- 
phenylethyl group (Figure 4) at the p-l position, and 
bound GrbZ-SH3 with a k, of 40 nM, two orders of mag- 
nitude higher than the affinity for the wild-type ligand. 
Moreover, this interaction is stereospecific, since the 
R-stereoisomer bound with a 103-fold lower affinity. Only 
modest gains in affinity were observed for several other 
SH3 domains, indicating that use of N-alkyl amino acids 
can enhance specificity as well as binding affinity. Similar 
specificity differences were observed when the same func- 
tional group was placed at the pZ position, with Crk-SH3 
showing the highest affinity in this case. The X-ray struc- 
ture of the Crk-SH3-peptide complex confirms that the 
ligand is bound in a PPII helix conformation (Figure lb). 
The N-alkyl group of the mutant residue turns inward and 
contacts the SH3 domain surface, as expected for residues 
at external binding sites. The methyl group of the N-(S)- 
phenylethyl moiety inserts into the proline-binding site, 
occupying a position equivalent to the P-carbon of a 
proline residue in a natural ligand at the pZ position [27]. 
The phenyl ring, however, is solvent exposed and no 
interactions with the SH3 domain are observed 
(Figure 2b). Interchanging the positions of the methyl and 
phenyl groups in the R-stereoisomer would lead to steric 
clashes because the size of the SH3-binding pocket 
cannot accommodate this ring system, explaining the low 
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affinity for the N-(R)-phenylethyl ligand. Interestingly, a 
similar ligand lacking the phenyl group showed only a 
modest gain in affinity for Crk-SH3, and no significant dif- 
ference in affinity was measured for a ligand with a phenyl 
group but lacking the methyl moiety. These data imply 
that the phenyl ring serves primarily to restrict the N-alkyl 
group to a conformation favorable for binding probably as 
a result of minimizing pseudo allylic1,3 interactions with 
substituents at Ca of the previous residue, and therefore 
has an entropic benefit for complex formation. 
Thfese findings encourage investigations to further enhance 
the binding affinity and selectivity of SH3 and WW domain 
ligands. The passive role of the aromatic ring in the N-(S)- 
phenylethyl group, for example, could be exploited by 
designing ligands with functional groups leading off the 
ring and making specific contacts with the surface of the 
SH3 domain. Nguyen et al. [4] have reported affinities for 
peptides containing a single N-alkyl residue. Further 
improvements in affinity and specificity could obviously be 
achieved by targeting both proline binding pockets simulta- 
neously. Such ligands would have the two conserved pro- 
lines replaced with N-alkylated residues that individually 
sho’w high affinity and selectivity for their respective 
binding sites. Improvement in specificity could also arise 
from the loss of orientational binding ambiguity observed 
for natural ligands. The near symmetrical sidechain geome- 
try apparently enables proline residues to make energeti- 
cally similar contacts with their targets, irrespective of 
binding orientation [15]. This will not be the case for 
N-substituted residues in general. 
The question arises why SH3- and WW-domain-ligand 
interactions have evolved without higher specificity for 
their ligands, rendering signaling pathways utilizing these 
modules susceptible to cross-talk. One answer could be 
that high-affinity binding with slow off rates would make 
it difficult for other regulatory proteins to intervene, and 
sig.nals would no longer be transient. High-affinity binding 
with high off rates has been observed in kinetics studies of 
several signaling systems, however, including SHZ-pTyr 
and CTPase-effector binding [28,29]. Alternatively, 
because signaling modules can act as molecular adapters, 
bringing together multiple interacting partners, they 
should be considered within the framework of a coordi- 
nated cellular structure. Even though the individual 
domain-ligand interactions may be of low affinity and rel- 
atively promiscuous, cooperativity can greatly increase 
affinity and specificity in higher-order complex formation, 
pol:entially without sacrificing the rapid kinetic character- 
istic of the separate binding events [30]. Cowburn et al. 
[31] have demonstrated that linking low-affinity SHZ and 
SH3 domain binding peptides can yield high affinity 
ligands targeting tandem SHZ-SH3 domains. In addition, 
the simultaneous accommodation of multiple binding 
units places more stringent requirements on target 
ligands. Sites accessible to binding in who, might be 
occluded in such complexes. An interaction observed 
in vitro might never occur in &JO because of different sub- 
cellular localization of the interacting partners. Specificity 
is thus distributed over a number of determinants. Finally, 
ambiguity in ligand binding could in itself be a means by 
which signals are modulated. Depending on other queues, 
a stimulus may activate more than one signaling pathway, 
and this might be an efficient means of accomplishing this 
task. In such cases the dynamic properties of the signaling 
assemblies might be particularly important in determining 
the balance of outputs and the resulting state of the cell. 
The work presented by Nguyen et al. [4] sheds further 
light into the mechanism whereby SH3 and WW domains 
recognize their ligands. Replacement of conserved proline 
residues by other N-substituted amino acids could yield 
ligands with improved selectivity and affinity toward indi- 
vidual SH3 and WW domains by making more extensive 
contacts with the surfaces of these domains. With the aid 
of such ligands, signaling through SH3 and WW domains 
could be selectively manipulated, elucidating the roles of 
the proteins involved, as well as the biological function of 
the individual pathways. From our increasing understand- 
ing of signal transduction pathways underlying diseases, 
targeting of specific protein-protein interactions has 
emerged as a means of therapy [32]. Drug delivery and 
specificity requirements necessitate therapeutic agents to 
be small molecules capable of traversing cell membranes 
in addition to being selectively bound by their targets. 
This, in turn, places stringent requirements on the binding 
sites of target proteins. The active sites of enzymes are 
designed to make extensive and highly specific contacts to 
small substrates, utilizing the resulting high binding 
energy for catalysis. These sites therefore provide suitable 
targets for inhibitory molecules. It has become evident, 
however, that SH3 and WW domains lack such sites, 
instead offering energetic binding potential spread across a 
relatively large surface area. Nguyen eta/. [4] have detailed 
how this potential is distributed, giving further insight into 
the feasibility of developing drugs targeting signaling 
pathways utilizing SH3 and WW domains. 
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